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Abstract 
Background: Dependence to prescription and over-the-counter (OTC) drugs represents an increasing public health 
and clinical problem both in England and internationally. However, relatively little is known about those affected, 
particularly in relation to their management at drug dependence treatment centres. This study aimed to explore the 
views and experiences of health care professionals (HCPs) working in formal drug treatment services in relation to 
supporting clients with prescription and OTC drug dependence.
Methods: An exploratory, qualitative design was used involving semi-structured telephone interviews. 15 staff were 
recruited using purposive sampling to represent a variety of different professional roles, funding (NHS, charity and 
local government) and geographical locations across England. Transcribed interviews were analysed using Braun and 
Clarke’s six stage thematic analysis.
Results: Current services were considered to be inappropriate for the treatment of OTC and prescription drug 
dependence, which was perceived to be a significantly under-recognised issue affecting a range of individuals but 
particularly those taking opioid analgesics. Negativity around current treatment services involved concerns that these 
were more suited for illicit drug users and this was exacerbated by a lack of specific resources, funding and commis-
sioning. There was a perceived variation in service provision in different areas and a further concern about the lack 
of formal treatment guidelines and care pathways. Participants felt there to be stigma for affected clients in both the 
diagnosis of OTC or prescription drug dependence and also attendance at drug treatment centres which adversely 
impacted service engagement. Suggested service improvements included commissioning new specific services in 
general practices and pain management clinics, developing national guidelines and care pathways to ensure equal 
access to treatment and increasing awareness amongst the public and HCPs.
Conclusions: This study reveals considerable negativity and concern about current treatment services for pre-
scription and OTC drug dependence in England from the perspective of those working in such services. Policy and 
practice improvement are suggested to improve outcomes for this neglected group in relation to increasing funding, 
guidelines and awareness.
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Background
he problematic use of licit drugs, including those avail-
able over-the-counter (OTC) from pharmacies, on pre-
scription and over the Internet represent an increasingly 
important public health problem in England and many 
other countries. Of most concern has been the potential 
for several medicines to be misused or abused, leading 
to dependence and addiction concerns. Implicated pre-
scription medicines include benzodiazepines, z-drugs, 
antidepressants, gabapentinoids and opioid analgesics 
[1] with around 8–12% of patients taking the latter being 
addiction [2].
Despite attempts to prevent harm through legislation 
to license and restrict supplies, and also provide train-
ing in appropriate prescribing, there were 9231 presenta-
tions at formal drug treatment services in 2016/2017 in 
England related to dependence to OTC or prescription 
drugs with males, and individuals aged between 35 and 
54 years old being more likely to present [3]. A key factor 
relates to the increased prescribing of medicines of mis-
use in England and many other countries. In 2017–2018, 
around a quarter of the adult population had been pre-
scribed one of the ive groups of medicines previously 
listed [4]. Although the need for upstream preventative 
measures is recognised as being important in this issue, 
treatment and support for those afected is also key. In 
England, for example, guidance was issued in 2013 to 
enable NHS and local authorities to commission ser-
vices to better support clients dependent on prescription 
and OTC drugs [5]. he National Treatment Agency for 
Substance Misuse (NTASM) highlighted that in some 
areas of England services for licit drug dependence have 
not been commissioned or are inaccessible [6]. A related 
concern is the lack of evidence to inform speciic clinical 
guidelines for licit opioid dependent treatment [7, 8]; the 
most recent UK guidelines for drug misuse and depend-
ence, published in 2017 remain centred around illicit 
drug treatment [9] and it has been noted that:
“overall, the evidence base to determine practice is 
weak [and] patients solely dependent on prescription 
or OTC opioids may respond diferently than heroin 
dependent patients […]” [9] pp 205–206
his emphasis on illicit drugs also characterises previ-
ous empirical research about treatment services and staf 
associated with these. Research has revealed negative 
attitudes towards illicit drug users from a range of health 
care professionals (HCPs) including general practitioners 
(GPs), psychiatrists, pharmacists and nursing staf [10, 
11] which may afect identiication, treatment and refer-
ral [12] and negatively inluence the care clients receive 
[13]. Clients who experience stigma are more likely to 
be reluctant to seek treatment for their problems [14]. 
Such evidence relates primarily to illicit substance mis-
use and relatively little is known about HCP attitudes and 
service use relating to treatment and support involving 
OTC and prescription drugs. hose afected have been 
recognised as a hard to reach group [15] who may be 
reluctant to present to HCPs and formal services due to 
their perceived diference to illicit drug using clients and 
not wanting their problems recorded formally [16]. Fin-
gleton et  al. [17] explored addiction treatment doctors’ 
views about non-prescription medicines and found many 
had experienced such clients’ unique needs but had little 
awareness of speciic treatment guidelines and perceived 
resources to be lacking.
Based on this relative lack of an evidence base the aim 
of this research was to explore the views and experiences 
of HCPs working in formal treatment services in relation 
to clients afected by OTC and prescription drug depend-
ence. Additional aims were to explore perceived difer-
ences between clients addicted to licit prescription and 
OTC drugs and illicit drugs, and to solicit views about 
the adequacy and appropriateness of current treatment 
and suggested improvements. Considerable variation 
in terminology exists in relation to this topic with the 
terms, misuse, abuse, dependence and addiction often 
being used interchangeably [18]; in this research the term 
dependence will be used throughout as is one widely 
associated with drug treatment services in the UK and 
appears in the current oicial drug treatment guidance 
[9] and was not intended to be stigmatizing.
Methods
A qualitative methodology comprising of semi-struc-
tured one-to-one telephone interviews was undertaken 
during the summer of 2018. Inclusion criteria were 
that participants had professional experience in deal-
ing with clients misusing OTC and prescription drugs 
within treatment centres in England. Participants were 
recruited through a purposive sampling method using 
geographical location, professional background and also 
type of organisation and funding (NHS, local government 
authority and charity drug treatment centres) [19]. Cen-
tres were initially identiied using the online drug support 
site FRANK, which provides a comprehensive search 
function to identify relevant services in a given area and 
associated contact details. Representation from a wide 
geographical area was undertaken as literature suggests 
there is regional variation in the UK of opioid prescrib-
ing, and also based on variation identiied in National 
Drug Treatment Monitoring System (NDTMS) data 
obtained via a freedom of information request from Pub-
lic Health England [3, 20]. Initial contact was made to a 
total of 80 centres by email with telephone follow-up if 
necessary.
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Data collection involved semi-structured interviews 
as they enabled direction to certain topics during the 
interview but also facilitated the emergence of dialogue 
between the participating interviewee and one of the 
research team who undertook and analysed all inter-
views [21]. Telephone interviews were utilised due to 
the geographically dispersed sample and digitally audio-
recorded using an encrypted digital recorder. Questions 
were developed from an initial literature review with 
some iterative modiications as the interviews and analy-
sis progressed. As noted the term ‘dependence’ was used 
generically in the research; the choice of this term was not 
intended to further stigmatize those afected, and partici-
pants were allowed to describe clients and services using 
any terminology they wanted. As the quotes that follow 
illustrate, reference was variously made to ‘dependence’ 
but also ‘addiction’. Interview duration ranged from 12 to 
32 min with most being around 30 min.
Interview recordings were transcribed verbatim and 
anonymously and subsequent inductive analysis was 
undertaken using Braun and Clarke’s six stages of thematic 
analysis [22]. hese involved initial data familiarisation fol-
lowed by code generation. hemes were then searched for 
using a mind mapping process, reviewed to identify over-
laps and inally deined and named using a thematic map. 
Data analysis occurred alongside data collection to permit 
theoretical saturation and also modiication of the inter-
view questions as appropriate as themes emerged [21]. 
Interviews were initially coded by hand to facilitate immer-
sion in the data and then codes were transferred onto 
NVivo 12 software to organise and complete analysis [19]. 
Initially the codes were semantic and close to the interview 
content but over time these emerged more with latent 
and less literal interpretations of the data [22]. University 
ethical approval was obtained as well as Health Research 
Authority approval to enable sampling in NHS sites prior 
to data collection. In total, 15 participants agreed to be 
interviewed and of these, 10 were from NHS funded cen-
tres, four were funded by charitable organisations and one 
was funded by the local government (Table  1). he inal 
sample size was determined by theoretical saturation of 
emerging themes occurring [23].
Results
Analysis revealed ive main themes with a number of 
additional sub-themes that could be characterised by 
considerable negativity, barriers, lack of recognition and 
diference for this client group. hese themes and sub-
themes are summarised in Table 2 and then described in 
more detail in turn using illustrative quotations.
Negativity towards current service
he overarching theme was a sense of negativity with all 
but one participant expressing varying degrees of nega-
tivity about current service provision in England for OTC 
and prescription medicine misuse clients. Such negativity 
was heightened due to concerns that this was an endur-
ing issue linked to problems in two main areas of current 
health services, namely specialised dependence services 
and also, more general primary and secondary care. 
here was a perceived inappropriateness of specialised 
dependence services for such clients, an absence of spe-
ciic treatment guidelines for this issue, and, omissions in 
prescribing review.
Table 1 Summary characteristics of participants
Participant number Role Service funding Gender Experience in drug 
dependence services (years)
P01 Clinical Specialist NHS/charity Male 10
P02 Senior Therapist Charity Female 20
P03 Clinical director/Consultant Psychiatrist NHS Male 7
P04 Open Access worker NHS Male 15
P05 Service Manager Charity Female 21
P06 Recovery Facilitator Local Government Female 2
P07 Consultant Dependence Psychiatry NHS Male 30
P08 Counselling Manager Charity Female 5
P09 Lead Consultant NHS Female 15
P10 General Practitioner (GP) NHS Female 15
P11 GP with special interest in drug and alcohol NHS Female 20
P12 Senior Nurse Practitioner NHS Male 24
P13 Nurse Lead NHS Male 22
P14 Recovery Worker NHS Female 5
P15 Recovery Worker NHS Male 15
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On‑going problem
All participants identiied OTC and prescription drug 
dependence as an enduring problem in their respective 
areas. It was also felt that there were signiicantly more 
people struggling with licit drug dependence than those 
who actually present and concern that national published 
igures signiicantly under-represent the actual number 
afected; the situation was described as being the “tip of 
an iceberg” (P04, P11) and as “just scratching the surface” 
(P01). Participants felt that it had been an increasing 
issue for many years that the NHS had failed to recognise:
“It is becoming a lot more prevalent with time, you 
know I’ve noticed a change in times.” (P02)
Comparisons were made between the OTC and pre-
scription drug dependence situation in England and 
the more widely media reported situation in the United 
States and it was argued the two were not dissimilar.
Inappropriate service
Participants perceived a distinct lack of service provision 
across most of the country. A few participants, primarily 
from the charity organisations, felt that although the cur-
rent services were appropriate, improvements could still 
be made. A lack of service commissioning meant centres 
were unable to provide tailored treatment to these clients 
resulting in the view that current services were inappro-
priate. A further concern was that current services were 
aimed at treating illicit and not licit drug dependence. 
Some participants felt that the provision of all drug and 
alcohol services together was not beneicial to clients:
“I think primarily we are geared up to serve those 
hard-core people, the people who are committing 
crime, who have come out of prison, who are inject-
ing, who are homeless et cetera et cetera. I don’t 
think drug services are geared up particularly well to 
deal with those people that have problems with OTC 
or prescribed medication.” (P15)
Participants believed that those addicted to licit drugs 
had complex needs, many of which were not addressed 
within current drug treatment centres. hey explained 
that this client group required a diferent treatment 
model due to their difering characteristics. A few partic-
ipants mentioned that there were inadequate alternative 
drugs to treat clients either with a history of, or at risk of, 
dependence. Furthermore, the lack of appropriate service 
provision was argued to be the reason why clients experi-
enced di culties in accessing treatment.
Lack of prescription review
Participants recognised additional problems beyond 
treatment services and in particular described the issue 
with prescription drug dependence, speciically, depend-
ence as a result of a lack of prescription review:
“[…] so many people have fallen into this trap of get-
ting repeat prescriptions from the doctors and not 
being reviewed regularly.” (P15)
It was felt that clients were able to remain on drugs for 
long periods of time without any type of review. Partici-
pants believed GPs were responsible for this and linked 
to a lack of awareness with no other health professionals 
being implicated. However, it was acknowledged that GPs 
in some areas of the country had recognised the issue and 
were conducting reviews but overall, it was still perceived 
to be inadequate given the scale of the issue.
Lack of pathways and guidelines
A further concern related to pathways and guidelines 
which were felt to be either absent or inappropriate and 
contributed to the lack of detection and poor manage-
ment of clients. Participants relected on experiences 
where they had witnessed clients being discharged from 
hospital on potentially addictive drugs without receiv-
ing a comprehensive discharge plan. As a result, clients 
remained on these drugs for longer than needed, increas-
ing the risk of dependency.
Participants highlighted the lack of comprehensive, 
clear treatment pathways for all drug detoxiication and 
reduction strategies and as a result, HCPs’ conidence 
to manage these clients in treatment centres was felt 
Table 2 Summary of main and sub-themes
Theme Subthemes
Negativity towards current service On-going problem
Inappropriate service
Lack of prescription review
Lack of pathways and guidelines
Service access barriers Stigma
Lack of service commissioning
Lack of awareness
Different and the same profile as 
illicit clients
Individual characteristics
Similarities to other dependencies
Drugs of dependence Ubiquity of Codeine
Reasons for initiating drug
Service improvement suggestions Improved commissioning and 
resource
Developing specific service
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compromised. In addition, the lack of formal referral pro-
tocols from primary to secondary care required proactive 
GPs to manage these clients appropriately. Experiences 
were recounted involving clients seeing multiple doctors 
who may be unaware of their full prescription history and 
a related concern that there is currently no system to eas-
ily identify clients on addictive drugs possibly resulting in 
unnecessary long- term use. Participants acknowledged 
the presence of HCPs across the country with speciic 
interests in this ield. However, they believed that treat-
ment guidelines needed to be standardised so that expe-
rience and skills could be shared nationally to ensure all 
clients received the best care:
“here’s a lot of good work happening around the 
county but there’s no concerted standardised guide-
lines or policies that support this efort.” (P03)
Service access barriers
he majority of the HCPs interviewed argued that there 
were signiicant barriers which impeded clients access-
ing treatment services for licit drug dependence; three 
key concerns emerged relating to the stigma surrounding 
dependence itself, a lack of commissioning and a lack of 
awareness.
Stigma
Many participants felt there was stigma associated 
with a diagnosis of drug dependence and additionally, 
attending drug treatment centres. Participants’ experi-
ences suggested that clients recognised this but viewed 
dependence on OTC and prescription drugs to be dif-
ferent and less problematic than other dependencies. 
Consequently, it was felt that clients dependent on 
licit drugs disassociated themselves with the typical 
client group that attended treatment centres for illicit 
drug dependence. Many clients were perceived to be in 
denial about their dependence, further hindering their 
willingness to approach HCPs about their problem:
“So, the experience can be that we see people who 
are quite reluctant to knock on our door because 
we are seen as the drug treatment team and they 
don’t access that support.” (P04)
he term “guilt” was often used and clients depend-
ent on OTC and prescription drugs were perceived by 
participants to hide their dependence due to shame and 
guilt, particularly in relation to prescription drugs, as 
they believe these are justiied and legal:
“[…] I think with prescription meds that’s kind 
of more common anyway than with any other 
dependence because the denial is stronger because 
it is so justiied, or they believe it is so justiied.” 
(P02)
Lack of service commissioning
A main concern of the participants was the lack of 
resources and inancing to help manage clients afected 
by licit drug dependence. Some participants were fur-
ther frustrated by the absence of speciic commission-
ing for clients with such drug dependence. Although 
participants felt they were capable of providing support 
to clients, the lack of commissioning meant they were 
unable to assist clients unless they presented with other 
dependencies that were commissioned. In addition, the 
lack of resources within commissioned services meant 
they were unable to provide individual support to this 
client group:
“I don’t think services are set up for anything other 
than alcohol and heroin use because they don’t 
really get funded so there’s nothing else really.” 
(P01)
Inconsistencies in commissioning were attributed to 
the particular interests of commissioning board mem-
bers. Participants believed this contributed to a “post-
code lottery” where clients were treated diferently 
across the country:
“I don’t think there’s enough commissioned support 
anywhere in the country, but you might get pock-
ets of good practice based on individual interest.” 
(P03)
One participant described a client who had recently 
moved house and had experienced diferent care as a 
result based on service commissioning variation:
“I know that some services are much more pre-
pared to go down that route of scripting1 and they 
don’t even need to see their key worker and my feel-
ings are that it is probably indicative of a lack of 
resources as opposed to a lack of human resources 
and them having the time to see the clients that 
often and hold groups, lack of that rather than a 
lack of wanting to do so […]” (P06)
1 In this case, the phrase scripting is being used to convey the practice of only 
issuing prescribed treatment and not offering anything else such as talking 
therapy or group support.
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Due to a lack of commissioning within drug treatment 
centres, much of the management of these clients fell 
to GPs. his raised concerns that time restrictions and 
a lack of skills and resources in GPs would compromise 
treatment:
“Unless they have got a special interest in this, they 
are not really sort of sure on how to deal with this” 
(P15)
“GPs don’t have that much time so yeah it’s just all 
about resources isn’t it.” (P01)
Lack of awareness
A commonly described barrier was the perceived lack 
of awareness. Participants felt that HCPs and also the 
general public were not only unaware of the potential 
dependence risk of OTC and prescription drugs, but, 
were also ignorant of how/where to access treatment if 
needed. Compounding this was a view that people do not 
see the issue as dependence as clients believed licit drugs 
helped with “real” medical issues:
“I don’t think people have a perception, you know the 
people that I’ve been in contact with, they’ve slipped 
into it very easily without realising how addictive 
the drugs are.” (P11)
Participants further highlighted the lack of understand-
ing of the diference between psychological and physical 
dependence to drugs and in particular trying to manage 
dependence without support:
“[…] it’s the same with any addictive drug or depend-
ence really…is people don’t understand the difer-
ence between psychological and physical dependence 
and how these dependencies actually…how dan-
gerous it is when you are planning on coming of of 
them.” (P06)
It was emphasised that HCPs operating outside drug 
treatment centres, or without a direct interest, were not 
aware of the prevalence of the issue and the available ser-
vices for referrals. his was felt to lead to under diagnosis 
and an increase in the prescribing of potentially addictive 
drugs without appropriate warnings advice.
Diferent but the same proile as illicit clients
In addition to the negativity and perceived barriers to 
OTC and prescription drug dependence, further themes 
emerged that related more to the clients and their attrib-
utes. What emerged was a sense that clients had shared 
some similarities to other groups such as illicit drug users 
but also key diferences. Views difered as to whether cli-
ents afected by licit medicines could be categorised but 
it was agreed that it could afect diferent genders, socio-
economic groups and ages:
“[…] I mean the thing with drug treatment over the 
years is you do get to that bit of wisdom that it can 
afect anybody, so some of them will be young, some of 
them will be old, the age diversity is quite striking.” (P04)
he majority reported primarily seeing middle-aged 
clients and rarely saw young people dependent on these 
drugs in their respective service work; more equivocal 
were views as to whether there was a pattern in presenta-
tion related to gender.
Individual characteristics
Participants described clients as “functioning” and often 
employed, with families and stable jobs. hey were also 
described as being knowledgeable and “computer savvy” 
(P07) and able to order drugs from the Internet.; OTC 
dependent clients in particular were perceived to attend 
multiple pharmacies to obtain drugs.
Similarities to other dependencies
Despite this participants reported that many clients 
exhibited analogous drug-seeking behaviours to those 
that illicit drug clients present with. heir experiences 
highlighted that some clients topped up their prescribed 
drugs with OTC drugs and that the majority of clients 
were not open about their dependence:
“Sometimes people aren’t very honest, they are keep-
ing it from their family, not really telling the truth 
about how much they are using, denial, all that kind 
of stuf.” (P01)
Participants described clients presenting with more 
than one type of dependence or with a history of depend-
encies, including illicit drug and alcohol dependence, sex 
and love addiction, eating disorders or gambling:
“It is quite commonly from what […] I’ve seen a lot 
of people who have, for example, used heroin in their 
younger years managed to maintain a level of absti-
nence and when they’ve relapsed it’s been on over the 
counter meds or you know prescription meds” (P14)
Clients were described as having complex issues that 
resulted in them taking a range of prescribed drugs:
“he main issue is about the needs, they’re complex, 
it’s mainly regarding mental issues like anxiety dis-
order, depression which is not addressed… it has to 
work around a holistic approach… not just looking 
at the substance dependence, looking at the needs 
in terms of prescribing, detoxing them or whatever” 
(P09)
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Drugs of dependence
All participants had seen clients dependent on licit drugs 
at some point during their career; a few suggested that 
they had seen more clients with prescription than OTC 
drug dependence. One GP explained that this might be 
related to their role as a prescriber, although other partic-
ipants, in both the charity and NHS sector, also described 
this trend.
Ubiquity of codeine
Codeine was the most commonly mentioned drug par-
ticularly as co-formulated with paracetamol or ibupro-
fen and participants readily cited popular OTC branded 
products in the UK:
“It is becoming more frequent that we have people in 
with Nurofen Plus and Solpadeine and Night Nurse 
and they are just incorporating all of this into their 
normal addictive behaviour.” (P02)
A greater range of prescription drugs were referred to 
as being problematic compared to OTC drugs; as well as 
prescribed codeine and other opioids such as tramadol, 
fentanyl and morphine, benzodiazepines and speciically 
diazepam were mentioned, along with zopiclone and 
other z drugs and pregabalin. Changing patterns of pres-
entation were also described based on the drug involved:
“he typical thing is dependence on codeine but 
more recently we have seen dependence on other 
drugs like pregabalin which are causing lots of issues 
really.” (P10)
Issues emerged in relation to how such medicines were 
obtained and as well as the previously mentioned issue of 
poor prescribing and review practices, internet and phar-
macy supply routes were also of concern. Many clients 
were remembered to have exhibited patterns of visiting 
difering pharmacies to obtain multiple supplies and few 
areas were considered to have robust reporting systems 
to monitor such supplies and personal use. he use of the 
internet to purchase drugs and in particular benzodiaz-
epines, was viewed as an increasing problem; fewer regu-
lations and the variety of online suppliers was considered 
to facilitate multiple purchases of the same drug:
“Somebody might be prescribed but they can be top-
ping up with all sorts online and I’ve noticed that 
with benzos, it’s quite a regular theme and also top-
ping up with street drugs.” (P04)
Many clients dependent on codeine were taking co-coda-
mol which contains paracetamol (acetaminophen) which 
represented an additional challenge during treatment, as 
any side efects (and possible risks of hepatotoxicity) would 
need to be managed in addition to the presenting issue.
Reasons for initiating drug
Although being primarily involved in treatment, partici-
pants regularly relected in interviews on how and why 
licit drug use began and recognised that treating pain and 
psychological issues such as anxiety and depression were 
most common. Of note was that use often changed and 
many participants had encountered clients prescribed 
codeine and pregabalin as analgesics using them subse-
quently to help with mental health issues. A key di culty 
was perceived to be the on-going nature of many painful 
conditions, which had not been resolved:
“[…] those individuals who still have existing physi-
cal health problems will be more challenging and 
more complex because it’s been diicult manag-
ing pain and then helping them of it and the whole 
issue around non-pharmacological interventions for 
pain are diicult things to deal with.” (P03)
Service improvement suggestions
Despite the sense of negativity surrounds this topic for 
participants, several suggestions were made about how 
current services could be improved, often linked to pre-
vious themes. Enhanced service commissioning and 
funding, development of national guidelines and refer-
ral pathways on the management of clients dependent on 
OTC and prescription drugs, and raising public and HCP 
awareness were all described as being beneicial changes.
Improved commissioning and resource
A repeated theme across all participants was recogni-
tion of the need for comprehensive and more consist-
ent commissioning of services along with an associated 
increase in resources. It was argued that this would lead 
to more equal access to treatment across England:
“A specialist drug treatment service should be com-
missioned to deal with anybody who has an issue 
with drug dependency.” (P13)
“With more staf, with more resources, more 
understanding from commissioners I think we 
could start making some headway, but that’s the 
main issue I think.” (P14)
Development of speciic service
he majority of HCPs felt a new speciic service for 
clients dependent on OTC and prescription drugs was 
needed or, at the very least, current services required 
adaptation and improvement. here were mixed views 
as to whether a speciic service should be incorporated 
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with other drug treatment centres or should be stand-
alone. Such services needed to ensure they could 
address the speciic needs of those afected, including 
extending opening hours for clients who were working. 
It was suggested that GPs or pain management clin-
ics could accommodate the service as this would help 
improve awareness and reduce stigma:
“We need a much more aggressive outreach service 
going into primary care which helps people under-
stand dependence to prescribed medication which 
helps people to seek help, which helps people take 
control of their prescription and reduce it them-
selves.” (P03)
Participants also highlighted the need for improved 
pain management services; many clients were perceived 
to have been prescribed opioids for pain relief without 
adequate dependence risk assessments. Furthermore, 
clients were often felt to have been prescribed opioids 
for conditions that could be managed with alternative 
drugs or therapies:
“I would say one of the main things that GPs and 
the National Health Service have to be aware of is 
the fact that when someone goes to them with an 
issue of pain management or anxiety, they need to 
ask them in depth about their use of alcohol and 
other types of drugs and ask them if they have ever 
been addicted to anything.” (P05)
Participants who advised adapting the current drug 
treatment services suggested difering access doors or 
clinic times enabling the segregation of clients depend-
ent on licit drugs and those dependent on illicit drugs 
or alcohol. his was deemed necessary to avoid tensions 
or a negative atmosphere in the waiting room between 
diferent client groups and remove the opportunity for 
interaction between difering vulnerable groups. It was 
also suggested that data recording systems within GPs 
could be coded to highlight clients taking addictive drugs 
to enable regular prescription reviews to take place. Fur-
thermore, a need for aftercare and support was para-
mount in order to reduce relapses; the use of fellowship 
groups such as Narcotics Anonymous was suggested but 
there was a need for appropriate advertising.
Improvement of guidelines and pathways
Participants highlighted a need to improve national treat-
ment guidelines and referral pathways to enable clients 
to access the required support and treatment across 
England. Participants reported that the lack of referral 
pathways into treatment services left primary care prac-
titioners unaware of where to direct patients; improved 
pathways would alleviate the burden on GPs. hey also 
described incomplete guidance on how to manage cer-
tain drug dependencies and highlighted the need for 
these to be improved:
“In terms of stuf like pregabalin, there isn’t anything 
basically, there really isn’t anything…we’ve nor-
mally…we haven’t got a pathway to how we would 
deal with that.” (P14)
Several suggestions were made about diferent forms 
of monitoring. A community pharmacy based system to 
report suspected dependent clients to their GP and other 
pharmacies was suggested.
Increasing awareness
Raising awareness of this issue amongst the public and 
HCPs was considered a necessity to reduce stigma, ena-
ble earlier detection and treatment, and, improve vigi-
lance amongst HCPs when prescribing addictive drugs. 
Wider and targeted advertising of the diferent services 
available felt would increase the number of clients access-
ing support. However, for several participants where to 
do this was more uncertain:
“[…] so I think there is a need for the message to get 
out there, somehow, yeah but where the message 
comes from I don’t know.” (P01)
“here’s a real, real hidden harm and I don’t feel 
as though there’s enough education around it but 
it’s where to implement that and it’s something that 
scares me you know, looking at America you can see 
how it happens…” (P06)
Some identiied more speciic opportunities such as 
between patients and prescribers and the need for spe-
ciic dialogue when drugs with recognised dependence 
potential were prescribed, including potential risks and 
possible reduction plans. Alongside increasing aware-
ness, participants highlighted the need for preven-
tion strategies within local authorities to reduce the 
number of people requiring treatment for licit drug 
dependence.
Professionals involvement
Various stakeholders were identiied as having a relevant 
role in the management of clients with licit drug depend-
ence including health care professionals in hospitals, 
GPs, drug and alcohol treatment centres, charity centres, 
pharmacists and online support forums. Key to success, 
though, was the need for better improved communica-
tion and HCP partnerships due to the unique and com-
plex needs of such clients:
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“he main issue is about the needs, they’re complex, 
they have, it’s mainly regarding mental issues like 
anxiety disorder, depression which is not addressed 
[…] he physical needs, chronic pain so there’s a lot 
of disjointed work between us, the pain clinic and 
the mental health services.” (P09)
Discussion
he main inding from the study was a sense of negativ-
ity around many aspects of current services in England 
for OTC and prescription drug dependence. Partici-
pants identiied downstream issues relating to treatment 
provision in terms of inadequate and inconsistent com-
missioning and funding, coupled with a lack of speciic 
treatment guidelines and care pathways and services 
which are designed primarily for illicit substance mis-
use. Insights into prevention were articulated and argued 
to arise in the inappropriateness of initial prescrib-
ing in primary and secondary care, primarily involving 
codeine-containing analgesics but with other drugs being 
recognised also. Key indings will now be considered in 
relation to previous research and evidence.
Negativity towards treatment guidelines
his study ofers a similarly negative account of treatment 
guideline awareness as identiied among doctors in the 
OTC only study by Fingelton et  al. [17]. Participants in 
this research argued that national referral pathways and 
treatment guidelines needed to be improved to ensure 
equal access to licit drug treatment. Existing publications 
[24] highlight the continued lack of specialist guidelines 
for treating OTC and prescription medicine depend-
ence. Current UK drug dependence treatment guidance 
[9] indeed recognises the limited evidence available to 
inform management of these clients [9].
Lack of funding and resource
HCPs were frustrated at their inability to provide support 
for these clients due to a lack of funding and resources, 
linked to wider commissioning concerns, which 
impacted negatively on attempts to reduce the prevalence 
of licit drug dependence within England. Commission-
ing in England is mainly undertaken locally and involves 
a range of activities related to the procurement of health 
services. As a result, commissioning of services can often 
be complex and vary by location. Fingleton et al. similarly 
reported resource and capacity concerns from UK doc-
tors working in substance misuse treatment services [17]. 
An NHS investigation into the commissioning of treat-
ment services for OTC and prescription drug depend-
ence also highlighted that treatment was not available 
across all of England and where it was available, may be 
inaccessible [6]. he need for commissioning was also 
reported by McCrorie et al. who explored GP and patient 
opinions on the factors behind long-term prescribing of 
opioids for chronic pain [25]. he authors concluded that 
commissioning was needed to improve access to appro-
priate specialist services. Of further concern is that UK 
policy guidance was published in 2013 to support NHS 
and local authority commissioners but this study sug-
gests such guidance has not resulted in change [5].
Client proile
Experience of previous clients provided participants with 
insights into the type of client or presentation encoun-
tered. In relation to implicated drugs, whilst a range was 
described, including pregabalin, tramadol, benzodiaz-
epines, diazepam, fentanyl and morphine, codeine was 
most frequently referred to. his relects existing evi-
dence and foci in the literature, where codeine-contain-
ing products and particularly those co-formulated with 
paracetamol or ibuprofen were considered particularly 
problematic in relation to harm [1, 7, 18, 26]. Existing 
literature suggests that those who are dependent on licit 
drugs may have certain characteristics. Although this 
study found that the majority of participants believed 
this issue could afect anybody, some felt clients there 
was a typical type of presentation, associated with cli-
ents who were middle-aged, knowledgeable, functioning, 
employed, often having families and/or possessing drug-
seeking behaviours. his inding was supported by previ-
ous research which found that clients dependent on OTC 
drugs had successful jobs, were knowledgeable and often 
had university qualiications [16, 27]. Opinions were 
divided as to whether presentations varied in relation to 
gender, which relects equivocal evidence in the literature 
also, such as OTC abuse for example [18]. UK prescrib-
ing treatment data suggests that whilst more males than 
females present with only prescription and OTC drug 
problems overall, the proportion of females reporting 
non-illicit medicine use as opposed to illicit substances is 
higher among females [6].
Service improvements
Various service improvements were suggested which 
were felt would improve client access but required fur-
ther resources to either reform existing services or cre-
ate a new speciic service. Future speciic services would 
have to meet the speciic needs of this client group, 
provide a holistic approach, and reduce stigma around 
attendance at drug treatment services. Ofering services 
in GP practices or pain management clinics were rec-
ommended where the former were argued to have ben-
eits of better access, and reducing stigma. Participants 
considered that GPs were best placed to take the lead 
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in managing clients with licit drug dependence. How-
ever, they acknowledged that a lack of resources, time 
and knowledge might be an issue. Early interventions 
in GP practices have been argued to reduce prescribing 
and increase service engagement but GPs may have di -
culty assimilating all prescribing information available to 
them [15] and some GPs do not consider general practice 
to be a suitable setting for codeine dependence manage-
ment [26]. Research has also suggested that clients may 
be reluctant to visit a GP due to conidentiality concerns, 
poor existing relationships, and desires to conceal their 
issues [16]. Furthermore, clients believed GPs consid-
ered OTC drug dependence to be less serious than other 
dependencies [16]. Establishing a specialist service within 
pain management clinics would enable HCPs to manage 
both the dependence and the initial reason for the drug 
prescription. A further suggestion made by all partici-
pants was for a collaborative system where GPs, pharma-
cies, drug treatment centres, and, mental health services 
worked much more closely to provide a holistic service. 
All stakeholders’ roles were considered necessary for 
the efective management of OTC and prescription drug 
dependence. his view was supported by earlier indings 
from NTASM where the importance of integrated ser-
vices, pain management services, and psychological ther-
apies was highlighted [6].
Raising awareness
he need to increase understanding of licit drug depend-
ence amongst the public and HCPs was another key 
emerging theme and recommendation. Previous research 
has identiied conlicting lay knowledge about drug risks 
and particularly dependence and addiction. Wazaify 
et al. [28] found that the general public in Northern Ire-
land were aware of the dependence potential of OTC 
drugs. A review of existing literature further supports 
this and suggested that resistance to medicine use was 
linked to “worries about dependence, tolerance and 
addiction” [29]. However, Roumie et  al. [30] found that 
the public perceived prescription drugs to be relatively 
safe because they are legal and users of OTC medicines 
appeared to continue as ‘dependent consumers’ even 
though they had considered risks [31]. Participants in 
this research stressed the need for increased aware-
ness amongst HCPs to ensure prescribing protocols for 
addictive drugs addressed the need for warnings advice 
and regular reviews. However, this may not be with-
out challenges, and there is evidence that doctors rarely 
question clients on their use of OTC drugs during con-
sultations [32]; European primary care doctors believed 
drug dependence treatment fell outside their remit and 
had inadequate knowledge to treat it [10]. Other research 
has identiied doctors’ high levels of awareness of codeine 
dependence potential and use of medicines reviews but 
also a lack of conidence and perceived resentment from 
patients when challenged [26]. In response to a demand 
for improved awareness amongst HCPs, the RCGP devel-
oped factsheets for primary and community care practi-
tioners but their value and success has not been assessed 
[33].
Strengths and limitations of the study
his study is the irst to explore experiences and percep-
tions of a range of substance misuse treatment work-
ers based on experiences of both prescription and OTC 
medicines in England. he use of qualitative methods and 
purposive sampling have ensured that a range of views 
can be captured in depth using an inductive approach 
that values the perspectives of those providing such ser-
vices. Study limitations relate to some interviews being 
shorter in duration than others due to participant time 
constraints and the logistical need to use telephone rather 
than face-to-face interviews that may have impacted 
somewhat on rapport. Purposive sampling was under-
taken but it was more di cult to recruit participants rep-
resenting the charity sector and these perspectives may 
be under-represented in this research. Similarly, whilst 
geographical location was used to inform the sampling 
also, it was not possible to represent all areas of England 
and so this research may not capture all areas and varia-
tions in commissioning and delivery of service may not 
be represented. his study relected staf views about cli-
ents presenting only with prescription or OTC medicine 
problems but it is recognised that such medicines, and 
particularly benzodiazepines, may be used concomitantly 
by illicit substance misusers, but this was beyond the 
scope of this study. It is also recognised that the choice 
of the term ‘dependency’ may have led the participants to 
relect and report on a particular type of client, although 
analysis of interviews suggested that synonymous terms 
were used to describe clients.
Conclusions
Substance misuse service staf expressed considerable 
negativity and frustration towards current service provi-
sion for clients with prescription and OTC drug depend-
ence in England. Services were not considered suitable 
for such clients who represent an important but under-
represented group, presenting often with codeine anal-
gesics but a range of other implicated licit medicines. 
Omissions were apparent in current guidelines and clini-
cal management plans and in service commissioning and 
resource with resulting inequity in access to appropriate 
services. Four key implications for policy and practice 
emerged in relation to (1) the need to introduce a new 
speciic service with perceived advantages in delivering 
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these in additional settings such as GP practices and 
pain clinics and involving more health professionals; (2) 
providing an improved and consistent commissioning 
process, (3) increasing public and health professional 
awareness and (4) developing dedicated guidelines for 
dependence to licit medicines.
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